When Should Oral Vancomycin Prophylaxis be Used to Prevent C. difficile Infection?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases
Link
https://link.springer.com/content/pdf/10.1007/s11908-023-00796-7.pdf
Reference25 articles.
1. • Maraolo AE, Mazzitelli M, Zappulo E, et al. Oral vancomycin prophylaxis for primary and secondary prevention of clostridioides difficile infection in patients treated with systemic antibiotic therapy: a systematic review, meta-analysis and trial sequential analysis. Antibiotics. 2022;11(2). https://doi.org/10.3390/antibiotics11020183. A systematic review that comprises several recent studies that are each discussed at length in this review paper. Overall, the meta-analysis yielded significant results, moderate heterogeneity, several subgroup analyses, and inclusion of both primary and secondary CDI prevention.
2. Singh T, Bedi P, Bumrah K, Singh J, Rai M, Seelam S. Updates in treatment of recurrent clostridium difficile infection. J Clin Med Res. 2019;11(7):465. https://doi.org/10.14740/jocmr3854.
3. Van Hise NW, Bryant AM, Hennessey EK, Crannage AJ, Khoury JA, Manian FA. Efficacy of oral vancomycin in preventing recurrent clostridium difficile infection in patients treated with systemic antimicrobial agents. Clin Infect Dis. 2016;63(5):651–3. https://doi.org/10.1093/cid/ciw401.
4. Carignan A, Poulin S, Martin P, et al. Efficacy of secondary prophylaxis with vancomycin for preventing recurrent clostridium difficile infections. Am J Gastroenterol. 2016;111(12):1834–40. https://doi.org/10.1038/ajg.2016.417.
5. Mcdonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of america (IDSA) and society for healthcare epidemiology of america (SHEA)Clin Infect Dis. 2018;66(7):e1. https://doi.org/10.1093/cid/cix1085.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3